|
|
 |
|
Viewing report
|
|
|
|
Palatin Technologies, Inc. (PTN) - Financial and Strategic SWOT Analysis Review
GlobalData, Sep 2011, Pages: 38
Palatin Technologies, Inc. (PTN) - Financial and Strategic SWOT Analysis Review
Summary
Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company, principally engaged in the development of peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. The product pipeline of Palatin consists of active development programs targeting melanocortin and natriuretic receptors, including products to treat congestive heart failure, obesity, metabolic syndrome and sexual dysfunction. Palatin has a strategic alliance with AstraZeneca AB for developing compounds that target melanocortin receptors to treat diabetes, obesity and related metabolic syndrome. Palatin's has 7 products in its pipeline,which are in various stages of clinical trials. The company is headquartered at Cranbury in New Jersey, the US.
Palatin Technologies, Inc. Key Recent Developments
Sep 22, 2011: Palatin Technologies Reports Q4 Fiscal 2010 Results
Jun 23, 2011: Palatin Technologies Appoints Alan Dunton To Board
Jun 15, 2011: Palatin Announces Presentation And Publication Of Report On Validation Of Scale For Subjective Male Sexual Arousal
May 16, 2011: Palatin Reports Net Loss Of $3.8m For Q3 Fiscal 2011
Feb 15, 2011: Palatin Reports Net Loss Of $1.1m For Q2 Fiscal 2011
This comprehensive SWOT profile of Palatin Technologies, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Palatin Technologies, Inc. - Product Pipeline Review - Q4 2010
Palatin Technologies, Inc. - Product Pipeline Review - Q4 2010
Nile Therapeutics, Inc. (NLTX) - Financial and Strategic SWOT Analysis Review
VIVUS, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review
Theratechnologies Inc. (TH) - Financial and Strategic SWOT Analysis Review
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Thallion Pharmaceuticals Inc. (TLN) - Financial and Strategic SWOT Analysis Review
Oramed Pharmaceuticals, Inc. (ORMP) - Financial and Strategic SWOT Analysis Review
BioSante Pharmaceuticals, Inc. (BPAX) - Financial and Strategic SWOT Analysis Review
Radient Pharmaceuticals Corporation (RXPC) - Financial and Strategic SWOT Analysis Review
|
|
|
|
